- Home
- GROV vs XTNT Comparison
GROV vs XTNT Comparison
Compare GROV & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- XTNT
- Stock Information
- Founded
- GROV 2016
- XTNT N/A
- Country
- GROV United States
- XTNT United States
- Employees
- GROV N/A
- XTNT N/A
- Industry
- GROV Package Goods/Cosmetics
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GROV Consumer Discretionary
- XTNT Health Care
- Exchange
- GROV Nasdaq
- XTNT Nasdaq
- Market Cap
- GROV 59.0M
- XTNT 55.6M
- IPO Year
- GROV N/A
- XTNT N/A
- Fundamental
- Price
- GROV $1.37
- XTNT $0.40
- Analyst Decision
- GROV Buy
- XTNT Strong Buy
- Analyst Count
- GROV 1
- XTNT 1
- Target Price
- GROV $2.00
- XTNT $3.00
- AVG Volume (30 Days)
- GROV 155.3K
- XTNT 218.6K
- Earning Date
- GROV 11-12-2024
- XTNT 11-12-2024
- Dividend Yield
- GROV N/A
- XTNT N/A
- EPS Growth
- GROV N/A
- XTNT N/A
- EPS
- GROV N/A
- XTNT N/A
- Revenue
- GROV $213,781,000.00
- XTNT $113,862,000.00
- Revenue This Year
- GROV N/A
- XTNT $31.82
- Revenue Next Year
- GROV $0.84
- XTNT $13.64
- P/E Ratio
- GROV N/A
- XTNT N/A
- Revenue Growth
- GROV N/A
- XTNT 45.11
- 52 Week Low
- GROV $1.19
- XTNT $0.33
- 52 Week High
- GROV $2.44
- XTNT $1.31
- Technical
- Relative Strength Index (RSI)
- GROV 44.30
- XTNT 45.25
- Support Level
- GROV $1.30
- XTNT $0.33
- Resistance Level
- GROV $1.43
- XTNT $0.39
- Average True Range (ATR)
- GROV 0.08
- XTNT 0.03
- MACD
- GROV -0.02
- XTNT 0.01
- Stochastic Oscillator
- GROV 29.54
- XTNT 72.67
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.